TW270927B - - Google Patents
Info
- Publication number
- TW270927B TW270927B TW082108510A TW82108510A TW270927B TW 270927 B TW270927 B TW 270927B TW 082108510 A TW082108510 A TW 082108510A TW 82108510 A TW82108510 A TW 82108510A TW 270927 B TW270927 B TW 270927B
- Authority
- TW
- Taiwan
- Prior art keywords
- antagonist
- present
- carbon
- oxytocin
- vasopressing
- Prior art date
Links
- 239000003336 oxytocin antagonist Substances 0.000 abstract 2
- 229940121361 oxytocin antagonists Drugs 0.000 abstract 2
- DQFQCHIDRBIESA-UHFFFAOYSA-N 1-benzazepine Chemical group N1C=CC=CC2=CC=CC=C12 DQFQCHIDRBIESA-UHFFFAOYSA-N 0.000 abstract 1
- 229940116211 Vasopressin antagonist Drugs 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000003038 vasopressin antagonist Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electric Connection Of Electric Components To Printed Circuits (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27758992 | 1992-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW270927B true TW270927B (enExample) | 1996-02-21 |
Family
ID=17585569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW082108510A TW270927B (enExample) | 1992-10-16 | 1993-10-14 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5622947A (enExample) |
| EP (2) | EP0620003B1 (enExample) |
| KR (1) | KR100291816B1 (enExample) |
| CN (2) | CN1306935C (enExample) |
| AT (1) | ATE383861T1 (enExample) |
| AU (1) | AU663628B2 (enExample) |
| CA (1) | CA2124696C (enExample) |
| DE (1) | DE69334199T2 (enExample) |
| DK (1) | DK0620003T3 (enExample) |
| ES (1) | ES2300101T3 (enExample) |
| MX (1) | MX9306425A (enExample) |
| TW (1) | TW270927B (enExample) |
| WO (1) | WO1994008582A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW270927B (enExample) * | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd | |
| CA2167198C (en) * | 1993-07-15 | 1999-03-16 | Kunio Satake | Benzylaminoquinuclidines |
| ATE360617T1 (de) * | 1994-06-15 | 2007-05-15 | Otsuka Pharma Co Ltd | Benzoheterocyclische verbindungen verwendbar als vasopressin- oder oxytocin-modulatoren |
| US5696112A (en) * | 1995-01-17 | 1997-12-09 | American Cyanamid Company | Fused heterocyclic azepines as vasopressin antagonists |
| TW359669B (en) * | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
| EP1050308A4 (en) | 1998-01-28 | 2002-09-04 | Senju Pharma Co | PREVENTIVE OR AGENT AGAINST VISUAL DISEASES |
| JP2002509888A (ja) * | 1998-03-27 | 2002-04-02 | オレゴン ヘルス サイエンシーズ ユニバーシティー | 腫瘍および他の過増殖性疾患の治療におけるビタミンｄおよびその類似体 |
| GB2355454A (en) * | 1999-10-20 | 2001-04-25 | Ferring Bv | Antidiuretic agents |
| GB0000079D0 (en) * | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| EP1283199A4 (en) * | 2000-05-16 | 2003-12-17 | Takeda Chemical Industries Ltd | MELANINE CONCENTRATING HORMONE ANTAGONISTS |
| US7202239B2 (en) * | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
| US7064120B2 (en) * | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| US6900200B2 (en) | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US7326700B2 (en) * | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| US7109193B2 (en) | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
| US6977254B2 (en) * | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| ATE517884T1 (de) * | 2001-04-27 | 2011-08-15 | Mitsubishi Tanabe Pharma Corp | 3,4-dihalobenzylpiperidinderivate und deren medizinische verwendung |
| AU2002342045C1 (en) * | 2001-10-12 | 2009-07-30 | Azevan Pharmaceuticals, Inc. | Beta-lactamyl vasopressin Vla antagonists |
| KR100632882B1 (ko) | 2001-11-16 | 2006-10-13 | 아스텔라스세이야쿠 가부시키가이샤 | 4, 4-디플루오로-1, 2, 3,4-테트라하이드로-5ｈ-1-벤즈아제핀 유도체 또는 그 염 |
| WO2005037796A1 (en) * | 2003-10-08 | 2005-04-28 | Eli Lilly And Company | Compounds and methods for treating dyslipidemia |
| TWI459947B (zh) * | 2007-06-26 | 2014-11-11 | Otsuka Pharma Co Ltd | 苯并氮呯化合物及藥學製劑 |
| CN102030709B (zh) * | 2009-09-25 | 2013-10-16 | 江苏豪森医药集团有限公司 | 用作加压素受体拮抗剂的苯并氮杂卓类化合物 |
| US11001564B2 (en) * | 2016-09-13 | 2021-05-11 | Arbutus Biopharma Corporation | Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same |
| WO2019003433A1 (ja) | 2017-06-30 | 2019-01-03 | 大塚製薬株式会社 | ベンゾアゼピン誘導体 |
| CN112851583B (zh) * | 2021-01-19 | 2023-09-08 | 徐州医科大学 | 新型苯并氮杂䓬类化合物、组合物及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3542760A (en) * | 1966-04-25 | 1970-11-24 | American Home Prod | 7-alkoxy-2,3,4,5-tetrahydro-1h-1-benzazepine and derivatives thereof |
| US3516987A (en) * | 1966-04-25 | 1970-06-23 | American Home Prod | 1-methylsulfonyl-7-methoxy-2,3,4,5-tetrahydro-1h-1-benzazepine |
| US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
| KR0167349B1 (ko) * | 1989-10-20 | 1999-02-18 | 오스카 아끼히꼬 | 벤조헤테로 고리 화합물 |
| JP2905909B2 (ja) * | 1991-04-19 | 1999-06-14 | 大塚製薬株式会社 | バソプレシン拮抗剤 |
| TW198715B (enExample) * | 1991-04-19 | 1993-01-21 | Dtsuka Seiyaku Kk | |
| TW270927B (enExample) * | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd |
-
1993
- 1993-10-14 TW TW082108510A patent/TW270927B/zh not_active IP Right Cessation
- 1993-10-15 AU AU51614/93A patent/AU663628B2/en not_active Expired
- 1993-10-15 WO PCT/JP1993/001483 patent/WO1994008582A1/ja not_active Ceased
- 1993-10-15 AT AT93922637T patent/ATE383861T1/de active
- 1993-10-15 DE DE69334199T patent/DE69334199T2/de not_active Expired - Lifetime
- 1993-10-15 US US08/244,424 patent/US5622947A/en not_active Expired - Lifetime
- 1993-10-15 EP EP93922637A patent/EP0620003B1/en not_active Expired - Lifetime
- 1993-10-15 CA CA002124696A patent/CA2124696C/en not_active Expired - Lifetime
- 1993-10-15 EP EP07021546A patent/EP1902717A3/en not_active Withdrawn
- 1993-10-15 DK DK93922637T patent/DK0620003T3/da active
- 1993-10-15 ES ES93922637T patent/ES2300101T3/es not_active Expired - Lifetime
- 1993-10-15 MX MX9306425A patent/MX9306425A/es active IP Right Grant
- 1993-10-15 KR KR1019940702053A patent/KR100291816B1/ko not_active Expired - Lifetime
- 1993-10-16 CN CNB971231559A patent/CN1306935C/zh not_active Expired - Lifetime
- 1993-10-16 CN CN93119219A patent/CN1039999C/zh not_active Expired - Lifetime
-
1996
- 1996-10-15 US US08/732,595 patent/US5753644A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU5161493A (en) | 1994-05-09 |
| CN1306935C (zh) | 2007-03-28 |
| US5622947A (en) | 1997-04-22 |
| EP0620003B1 (en) | 2008-01-16 |
| EP1902717A3 (en) | 2008-08-06 |
| KR100291816B1 (ko) | 2001-10-24 |
| MX9306425A (es) | 1994-05-31 |
| DK0620003T3 (da) | 2008-05-26 |
| EP1902717A2 (en) | 2008-03-26 |
| CN1183277A (zh) | 1998-06-03 |
| ES2300101T3 (es) | 2008-06-01 |
| CN1039999C (zh) | 1998-09-30 |
| CA2124696C (en) | 2005-01-04 |
| ATE383861T1 (de) | 2008-02-15 |
| DE69334199D1 (de) | 2008-03-06 |
| AU663628B2 (en) | 1995-10-12 |
| DE69334199T2 (de) | 2009-01-15 |
| EP0620003A1 (en) | 1994-10-19 |
| CN1098716A (zh) | 1995-02-15 |
| EP0620003A4 (en) | 1995-02-15 |
| WO1994008582A1 (fr) | 1994-04-28 |
| CA2124696A1 (en) | 1994-04-28 |
| US5753644A (en) | 1998-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0620003A4 (en) | VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST. | |
| TW288011B (enExample) | ||
| CA2165819A1 (en) | Dc-89 derivatives | |
| DE69321845D1 (en) | Hydroxyethylaminosulfonamide verwendbar als inhibitoren retroviraler proteasen | |
| EP0669324A4 (en) | CHINAZOLIN DERIVATIVES. | |
| CA2288122A1 (en) | Neuropeptide y receptor antagonist | |
| ES2139079T3 (es) | Compuestos inmunosupresores y antialergicos, tales como n-(3-oxohexanoil)-homoserina-lactona. | |
| BG103485A (en) | Ketobanzamides as calpain inhibitors | |
| HUT69026A (en) | Carbamates and fungicidal compositions containing them | |
| MY102741A (en) | Imidazole compounds and biocidal composition comprising the same for controlling harmful organisms | |
| EP0219876A3 (en) | Antihypertensive agents comprising 2-alkynyladenosines as active ingredients | |
| CA2096408A1 (en) | Retroviral protease inhibitors | |
| SG52593A1 (en) | Azole compounds their production and use | |
| TW223637B (enExample) | ||
| CA2129542A1 (en) | Pharmaceutical preparation based on rhamnolipid | |
| CA2289787A1 (en) | Fungicidal mixtures | |
| CA2135997A1 (en) | Fungicidal composition | |
| GB9325618D0 (en) | New herbicides | |
| MY104162A (en) | A hydrazone compound and production therefor, and an insecticidal composition containing the same. | |
| CA2111955A1 (en) | Novel tetracyclic compound | |
| DE69416003D1 (en) | Kristalline, polymorphische form von (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosin | |
| CA2025858A1 (en) | Antihepatopathic composition | |
| EP0604667A4 (en) | TRANEXAMIC ACID DERIVATIVE AND DERMATOLOGICAL PREPARATION CONTAINING THE SAME. | |
| EP0582713A4 (enExample) | ||
| WO1991019703A3 (en) | Fungicidal iminooxazolidinones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Expiration of patent term of an invention patent |